Accelr8 Technology Corp (NYSEMKT:AXK)

CAPS Rating: No stars

The Company intends to customize its technologies to the specific requirements of large licensees as well as develop new rapid pathogen detection assays.

Results 1 - 3 of 3

Recs

2
Member Avatar FAOFool (75.15) Submitted: 8/30/2011 11:51:33 PM : Outperform Start Price: $3.17 AXK Score: -33.66

Solid financials support long-term technology development.

Recs

1
Member Avatar DaveKetelhohn (< 20) Submitted: 8/8/2011 2:54:57 PM : Outperform Start Price: $2.57 AXK Score: -17.33

A technology needed by hospitals to more quickly diagnose MSRA? How can this stock not improve?

Recs

1
Member Avatar jryan262 (< 20) Submitted: 3/23/2011 10:48:19 AM : Outperform Start Price: $3.97 AXK Score: -51.37

I attended the annual meeting this past summer and was extremely impressed with the technology, the physicians attending, and the "off the wall" parts approach they have with building their prototypes.

Results 1 - 3 of 3

Featured Broker Partners


Advertisement